Adapting The Adpkd Outcomes Model to Predict Cost Consequence In Italian Patients With Autosomal Dominant Polycystic Kidney Disease (Adpkd) Treated With Jinarc (Tolvaptan)
Abstract
Authors
FS Mennini A Marcellusi S Russo A Iorio EP Lanati P Robinson